Clinical Trial

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients

Name: Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients — clinical trial record (NCT06606093)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the efficacy and safety of DWP16001 in type 2 diabetic nephropathy with moderate renal impairment patients (CKD stage 3)

Trial Details

NCT Number	NCT06606093
Lead Sponsor	Daewoong Pharmaceutical Co. LTD.
Conditions	Type 2 Diabetic Nephropathy
Enrollment	348 participants
Start Date	2024-09-23
Primary Completion	2026-09-01 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2024-09-20